Implantable cardioverter-defibrillator (ICD) therapy is clearly an effective therapy for selected
patients in definable populations. The benefits and risks of ICD therapy are directly impacted …

Background Antitachycardia pacing (ATP) is an established implantable cardioverter-
defibrillator (ICD) therapy that terminates ventricular tachycardias (VTs) without painful ICD …

Background: Antitachycardia pacing (ATP) in implantable cardioverter-defibrillators (ICD)
decreases patient shock burden but has recognized limitations. A new automated ATP …

Multiple Bursts for Fast Ventricular Tachycardia Introduction An empirical sequence of burst
antitachycardia pacing (ATP) is effective in terminating fast ventricular tachycardias (FVT) in …

Antitachycardia pacing (ATP) strategies represent safe, effective, and painless therapy for
ventricular tachyarrhythmias, with a large body of clinical evidence supporting their routine …

Introduction and objectives Fast ventricular tachycardias in the ventricular fibrillation zone in
patients with an implantable cardioverter-defibrillator are susceptible to antitachycardia …

Background Despite concerns about complications with the implantable cardioverter
defibrillator (ICD), it is effective for the prevention of sudden cardiac death (SCD). We aimed …

Although implantable cardioverter-defibrillators (ICDs) have proven to be life-saving
devices, there are frequent complications associated with their use, especially in the …

Background: Tetralogy of Fallot (TOF) is one of the common congenital heart diseases
(CHD) in implantable cardioverter defibrillator (ICD) recipients, but few studies have …

Background Anti‐tachycardia pacing (ATP) delivered from an implantable device is a useful
tool to terminate ventricular tachycardia (VT). But its real‐world efficacy for those patients …